April 18, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 81,738 shares of Abrdn Life Sciences Investors at $12.80 per share, a transaction worth $1.05M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.